Advertisement

Breast Cancer Screening Modalities, Recommendations, and Novel Imaging Techniques

Published:October 17, 2022DOI:https://doi.org/10.1016/j.suc.2022.08.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smith R.A.
        • Andrews K.S.
        • Brooks D.
        • et al.
        Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.
        CA Cancer J Clin. 2019; 69: 184-210
        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer statistics, 2022.
        CA Cancer J Clin. 2022; 72: 7-33
      1. Radiation Dose to Adults from Common Imaging Examinations.
        (ACR Available at:)
      2. Calculate Your Radiation Dose.
        (EPA Available at:)
        • Garayoa J.
        • Hernandez-Giron I.
        • Castillo M.
        • et al.
        Fujita H. Hara T. Muramatsu C. Digital breast tomosynthesis: image quality and dose Saving of the Synthesized image. Breast imaging. IWDM 2014. Lecture notes in computer Science. 8539. Springer, Cham2014https://doi.org/10.1007/978-3-319-07887-8_22
        • Sickles E.A.
        • D'Orsi C.J.
        ACR BI-RADS Follow-up and Outcome Monitoring.
        in: D'Orsi C.J. Sickles E.A. Mendelson E.B. ACR BI-RADS atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA2013 ([Google Scholar])
        • Lee C.S.
        • Moy L.
        • Friedewald S.M.
        • et al.
        Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability.
        AJR Am J Roentgenol. 2018; 210: 241-245
        • Smith R.A.
        • Duffy S.W.
        • Gabe R.
        • et al.
        The randomized trials of breast cancer screening: what have we learned?.
        Radiol Clin North Am. 2004; 42: 793-v
        • Tabár L.
        • Yen A.M.
        • Wu W.Y.
        • et al.
        Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs.
        Breast J. 2015; 21: 13-20
        • Oeffinger K.C.
        • Fontham E.T.
        • Etzioni R.
        • et al.
        Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [published correction appears in JAMA.
        JAMA. 2015; 314 (1406): 1599-1614
        • Narayan A.K.
        • Lee C.I.
        • Lehman C.D.
        Screening for Breast Cancer.
        Med Clin North Am. 2020; 104: 1007-1021
        • Broeders M.
        • Moss S.
        • Nyström L.
        • et al.
        The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.
        J Med Screen. 2012; 19: 14-25
        • Coldman A.
        • Phillips N.
        • Wilson C.
        • et al.
        Pan-Canadian study of mammography screening and mortality from breast cancer [published correction appears in.
        J Natl Cancer Inst. 2015; 107: dju404
        • Pocobelli G.
        • Weiss N.S.
        Breast cancer mortality in relation to receipt of screening mammography: a case-control study in Saskatchewan, Canada.
        Cancer Causes Control. 2015; 26: 231-237
        • Yen A.M.
        • Tsau H.S.
        • Fann J.C.
        • et al.
        Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
        JAMA Oncol. 2016; 2: 915-921
        • Morrell S.
        • Taylor R.
        • Roder D.
        • et al.
        Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
        Br J Cancer. 2017; 116: 828-839
        • Moss S.M.
        • Nyström L.
        • Jonsson H.
        • et al.
        The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies.
        J Med Screen. 2012; 19: 26-32
        • Narayan A.K.
        • Lehman C.D.
        Mammography Screening Guideline Controversies: Opportunities to Improve Patient Engagement in Screening.
        J Am Coll Radiol. 2020; 17: 633-636
        • Badgwell B.D.
        • Giordano S.H.
        • Duan Z.Z.
        • et al.
        Mammography before diagnosis among women age 80 years and older with breast cancer.
        J Clin Oncol. 2008; 26: 2482-2488
        • Brawley O.
        • Byers T.
        • Chen A.
        • et al.
        New American Cancer Society process for creating trustworthy cancer screening guidelines.
        JAMA. 2011; 306: 2495-2499
        • Miglioretti D.L.
        • Zhu W.
        • Kerlikowske K.
        • et al.
        Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
        JAMA Oncol. 2015; 1: 1069-1077
        • Harris R.P.
        • Helfand M.
        • Woolf S.H.
        • et al.
        Current methods of the US Preventive Services Task Force: a review of the process.
        Am J Prev Med. 2001; 20: 21-35
        • Nelson H.D.
        • Pappas M.
        • Cantor A.
        • et al.
        Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
        Ann Intern Med. 2016; 164 ([published correction appears in Ann Intern Med. 2018 Nov 20;169(10):740]): 256-267
        • Puliti D.
        • Duffy S.W.
        • Miccinesi G.
        • et al.
        Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
        J Med Screen. 2012; 19: 42-56
      3. Breast Cancer Surveillance Consortium. Breast Cancer Surveillance Consortium.
        (Available at URL:) (Accessed July 09, 2020)
        • Hubbard R.A.
        • Kerlikowske K.
        • Flowers C.I.
        • et al.
        Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
        Ann Intern Med. 2011; 155 ([published correction appears in Ann Intern Med. 2014 May 6;160(9):658]): 481-492
        • Tosteson A.N.
        • Fryback D.G.
        • Hammond C.S.
        • et al.
        Consequences of false-positive screening mammograms.
        JAMA Intern Med. 2014; 174: 954-961
        • Lehman C.D.
        • Arao R.F.
        • Sprague B.L.
        • et al.
        National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
        Radiology. 2017; 283: 49-58
        • Nelson H.D.
        • O'Meara E.S.
        • Kerlikowske K.
        • et al.
        Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
        Ann Intern Med. 2016; 164: 226-235
        • Berg W.A.
        Benefits of screening mammography.
        JAMA. 2010; 303: 168-169
        • Burnside E.S.
        • Park J.M.
        • Fine J.P.
        • et al.
        The use of batch reading to improve the performance of screening mammography.
        AJR Am J Roentgenol. 2005; 185: 790-796
        • Froicu M.
        • Mani K.L.
        • Coughlin B.
        Satisfaction With Same-Day-Read Baseline Mammography.
        J Am Coll Radiol. 2019; 16: 321-326
        • Dontchos B.N.
        • Narayan A.K.
        • Seidler M.
        • et al.
        Impact of a Same-Day Breast Biopsy Program on Disparities in Time to Biopsy.
        J Am Coll Radiol. 2019; 16: 1554-1560
        • Lehman C.D.
        • Yala A.
        • Schuster T.
        • et al.
        Mammographic Breast Density Assessment Using Deep Learning: Clinical Implementation.
        Radiology. 2019; 290: 52-58
      4. NCCN Guidelines Version 1.2021 Breast Cancer Screening and Diagnosis.

      5. NCCN Guidelines Version 1.2022 Breast Cancer Risk Reduction.

        • Claus E.B.
        • Schildkraut J.M.
        • Thompson W.D.
        • et al.
        The genetic attributable risk of breast and ovarian cancer.
        Cancer. 1996; 77: 2318-2324
      6. The American Society of Breast Surgeons website. Position statement on screening mammography.
        (Available at:)
        • Monticciolo D.L.
        • Newell M.S.
        • Moy L.
        • et al.
        Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
        J Am Coll Radiol. 2018; 15: 408-414
        • Saslow D.
        • Boetes C.
        • Burke W.
        • et al.
        American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
        CA Cancer J Clin. 2007; 57 ([published correction appears in CA Cancer J Clin. 2007 May-Jun;57(3):185]): 75-89
        • McCormack V.A.
        • dos Santos Silva I.
        Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
        Cancer Epidemiol Biomarkers Prev. 2006; 15: 1159-1169
        • Yaghjyan L.
        • Colditz G.A.
        • Rosner B.
        • et al.
        Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors.
        Breast Cancer Res Treat. 2015; 150: 181-189
      7. DenseBreast-Info. Legislation and regulation.
        (Available at) (Google Scholar)
        • Ciatto S.
        • Houssami N.
        • Bernardi D.
        • et al.
        Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
        Lancet Oncol. 2013; 14: 583-589
        • Weinstein S.P.
        • Slanetz P.J.
        • et al.
        • Expert Panel on Breast Imaging
        ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density.
        J Am Coll Radiol. 2021; 18: S456-S473
        • Svahn T.M.
        • Houssami N.
        • Sechopoulos I.
        • et al.
        Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view full-field digital mammography.
        Breast. 2015; 24: 93-99
        • Skaane P.
        • Bandos A.I.
        • Gullien R.
        • et al.
        Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program.
        Radiology. 2013; 267: 47-56
        • Friedewald S.M.
        • Rafferty E.A.
        • Rose S.L.
        • et al.
        Breast cancer screening using tomosynthesis in combination with digital mammography.
        JAMA. 2014; 311: 2499-2507
        • Rafferty E.A.
        • Durand M.A.
        • Conant E.F.
        • et al.
        Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts.
        JAMA. 2016; 315: 1784-1786
        • Houssami N.
        Digital breast tomosynthesis (3D-mammography) screening: data and implications for population screening.
        Expert Rev Med Devices. 2015; 12: 377-379
        • Berg W.A.
        • Blume J.D.
        • Cormack J.B.
        • et al.
        Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
        JAMA. 2008; 299 ([published correction appears in JAMA. 2010 Apr 21;303(15):1482]): 2151-2163
        • Ohuchi N.
        • Suzuki A.
        • Sobue T.
        • et al.
        Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
        Lancet. 2016; 387: 341-348
        • Weigert J.
        • Steenbergen S.
        The connecticut experiments second year: ultrasound in the screening of women with dense breasts.
        Breast J. 2015; 21: 175-180
        • Kuhl C.K.
        • Schrading S.
        • Leutner C.C.
        • et al.
        Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
        J Clin Oncol. 2005; 23: 8469-8476
        • Sung J.S.
        • Stamler S.
        • Brooks J.
        • et al.
        Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
        Radiology. 2016; 280: 716-722
        • Bakker M.F.
        • de Lange S.V.
        • Pijnappel R.M.
        • et al.
        Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
        N Engl J Med. 2019; 381: 2091-2102
        • Rhodes D.J.
        • Hruska C.B.
        • Phillips S.W.
        • et al.
        Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.
        Radiology. 2011; 258: 106-118
        • Rhodes D.J.
        • Hruska C.B.
        • Conners A.L.
        • et al.
        Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.
        AJR Am J Roentgenol. 2015; 204: 241-251
        • Shermis R.B.
        • Wilson K.D.
        • Doyle M.T.
        • et al.
        Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue.
        AJR Am J Roentgenol. 2016; 207: 450-457
        • Hruska C.B.
        Let's Get Real about Molecular Breast Imaging and Radiation Risk.
        Radiol Imaging Cancer. 2019; 1 (Published 2019 Sep 27): e190070
        • Jochelson M.S.
        • Lobbes M.B.I.
        Contrast-enhanced Mammography: State of the Art.
        Radiology. 2021; 299: 36-48https://doi.org/10.1148/radiol.2021201948
        • Sung J.S.
        • Lebron L.
        • Keating D.
        • et al.
        Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer.
        Radiology. 2019; 293: 81-88
        • Chen S.Q.
        • Huang M.
        • Shen Y.Y.
        • et al.
        Application of Abbreviated Protocol of Magnetic Resonance Imaging for Breast Cancer Screening in Dense Breast Tissue.
        Acad Radiol. 2017; 24: 316-320
        • Comstock C.E.
        • Gatsonis C.
        • Newstead G.M.
        • et al.
        Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
        JAMA. 2020; 323 ([published correction appears in JAMA. 2020 Mar 24;323(12):1194]): 746-756
        • Banegas M.P.
        • Li C.I.
        Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women.
        Breast Cancer Res Treat. 2012; 134: 1297-1304
        • Stapleton S.M.
        • Oseni T.O.
        • Bababekov Y.J.
        • et al.
        Race/Ethnicity and Age Distribution of Breast Cancer Diagnosis in the United States.
        JAMA Surg. 2018; 153: 594-595
        • Monticciolo D.L.
        • Malak S.F.
        • Friedewald S.M.
        • et al.
        Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging.
        J Am Coll Radiol. 2021; 18: 1280-1288
        • Perry H.
        • Fang A.J.
        • Tsai E.M.
        • et al.
        Imaging Health and Radiology Care of Transgender Patients: A Call to Build Evidence-Based Best Practices.
        J Am Coll Radiol. 2021; 18: 475-480